Vanda Pharmaceuticals Announces Participation in the 2024 Cantor Global Healthcare Conference
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) has announced its participation in the 2024 Cantor Global Healthcare Conference in New York City on September 19, 2024. The company is scheduled for a fireside chat at 8:00 a.m. Eastern Time. Investors can access the live chat on Vanda's corporate website under the Investors tab and Recent Events section.
Attendees are advised to arrive at the conference website 15 minutes early to register and set up any necessary software. The archived conference will be available on Vanda's website for approximately 30 days following the event.
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) ha annunciato la sua partecipazione alla Conferenza Sanitaria Globale Cantor 2024 a New York City, il 19 settembre 2024. L'azienda è programmata per un colloquio informale alle 8:00 ora dell'Est. Gli investitori possono accedere alla chat dal vivo sul sito web aziendale di Vanda nella sezione Investitori e Eventi Recenti.
Si consiglia ai partecipanti di arrivare al sito della conferenza 15 minuti prima per registrarsi e configurare eventuali software necessari. La conferenza registrata sarà disponibile sul sito di Vanda per circa 30 giorni dopo l'evento.
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) ha anunciado su participación en la Conferencia Global de Salud Cantor 2024 en la ciudad de Nueva York el 19 de septiembre de 2024. La empresa tiene programada una charla informal a las 8:00 a.m. hora del Este. Los inversores pueden acceder a la charla en vivo en el sitio web corporativo de Vanda en la pestaña de Inversores y en la sección de Eventos Recientes.
Se aconseja a los asistentes que lleguen al sitio de la conferencia 15 minutos antes para registrarse y configurar cualquier software necesario. La conferencia archivada estará disponible en el sitio web de Vanda durante aproximadamente 30 días después del evento.
반다 제약 주식회사 (Nasdaq: VNDA)는 2024년 9월 19일 뉴욕에서 열리는 2024 칸토 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사는 동부 표준시 기준 오전 8시에 화상 대화를 예정하고 있습니다. 투자자들은 반다의 기업 웹사이트에서 라이브 채팅에 접속할 수 있습니다 인베스터 탭과 최근 이벤트 섹션에서 확인할 수 있습니다.
참석자는 등록하고 필요한 소프트웨어를 설정하기 위해 컨퍼런스 웹사이트에 15분 일찍 도착할 것을 권장합니다. 기록된 컨퍼런스는 이벤트 이후 약 30일간 반다 웹사이트에서 이용 가능합니다.
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) a annoncé sa participation à la Conférence Mondiale sur la Santé Cantor 2024 à New York le 19 septembre 2024. La société est prévue pour une discussion informelle à 8h00, heure de l'Est. Les investisseurs peuvent accéder au chat en direct sur le site web de la société Vanda dans l'onglet Investisseurs et la section Événements Récents.
Il est conseillé aux participants d'arriver sur le site de la conférence 15 minutes à l'avance pour s'inscrire et configurer tout logiciel nécessaire. La conférence archivée sera disponible sur le site de Vanda pendant environ 30 jours après l'événement.
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) hat seine Teilnahme an der 2024 Cantor Global Healthcare Conference in New York City am 19. September 2024 bekannt gegeben. Das Unternehmen ist für ein informelles Gespräch um 8:00 Uhr Eastern Time eingeplant. Investoren können auf den Live-Chat über die Unternehmenswebsite von Vanda zugreifen unter dem Reiter Investoren und im Abschnitt Aktuelle Ereignisse.
Teilnehmern wird geraten, 15 Minuten früher auf der Konferenzwebsite zu erscheinen, um sich zu registrieren und notwendige Software einzurichten. Die archivierte Konferenz wird für etwa 30 Tage nach der Veranstaltung auf Vandas Website verfügbar sein.
- None.
- None.
The fireside chat given at the 2024 Cantor Global Healthcare Conference may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-2024-cantor-global-healthcare-conference-302245674.html
SOURCE Vanda Pharmaceuticals Inc.
FAQ
When is Vanda Pharmaceuticals (VNDA) participating in the 2024 Cantor Global Healthcare Conference?
How can investors access Vanda Pharmaceuticals' (VNDA) fireside chat at the 2024 Cantor Global Healthcare Conference?
How long will the archived conference be available on Vanda Pharmaceuticals' (VNDA) website?
